Page 19 - Nov 4 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nov 4. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nov 4 Today - Breaking & Trending Today

Certa Therapeutics' investigational drug FT011 delivers breakthrough results as a potential novel treatment for serious inflammatory and fibrotic diseases

Research presented today by University of Michigan Medical School highlights FT011's ground-breaking treatment potential from human expression profiles in chronic kidney disease study supported by animal model data The research demonstrated that treatment with FT011 results in a remarkable reversal in the activation of genetic markers associated with fibrosis Fibrosis is responsible for 45 percent of all deaths globally - FT011 is a novel drug with potential to treat chronic fibrosis in multiple organs such as the kidneys, skin, lungs, heart, and eyes Certa Therapeutics is a clinical stage biotechnology company based in Melbourne, Australia, developing innovative therapies for the treatment of fibrotic diseases ANN ARBOR, Mich., Nov. 4, 2022 /PRNewswire/ New research presented today by the University of Michigan reveals ground-breaking results for Certa Therapeutics' FT011, a novel potential treatment of serious inflammatory and fibrotic diseases. The results in a chronic kid ....

United States , Matthias Kretzler , Darren Kelly , Rare Disease Clinical Research Network , National Center , Nephrotic Syndrome Study Network , Translational Sciences , University Of Michigan , Nephcure Kidney International , University Of Michigan Medical School Professor , Halpin Foundation , American Society Of Nephrology , University Of Michigan Medical School , Alport Syndrome Foundation , Michigan Medical School , Certa Therapeutic , Kidney Week , American Society , Professor Darren Kelly , Focal Segmental Glomerulosclerosis , Membranous Nephropathy , Michigan Medical School Professor , Lacerta Therapeutics , Minimal Changes Disease , Nephrotic Syndrome , Advancing Translational Sciences ,

HashKey Capital Singapore Secures In-Principle Approval for the Capital Markets Services License from the Monetary Authority of Singapore

SINGAPORE, Nov. 4, 2022 /PRNewswire/ HashKey Capital Singapore Pte. Ltd. ("HashKey Capital Singapore", and together with its affiliates, the "HashKey Group") announced at Singapore Fintech Festival 2022 that it has received its in-principle approval for the Capital Markets Services ("CMS") license from the Monetary Authority of Singapore ("MAS") as a licensed fund management company (LFMC). When granted, the CMS license will allow HashKey Capital Singapore to conduct fund management services from Singapore. HashKey Capital Singapore, part of HashKey Capital, prides itself as a company which takes the next step in bringing digital assets closer to mainstream institutional adoption. "Singapore is quickly becoming the region's epicentre of Web3 innovation. Being recognised by the MAS as a licensed fund management company will allow HashKey Capital Singapore to contribute to and support the local Web3 community, which is considered a signif ....

Hong Kong , Deng Chao , Hashkey Group , Capital Markets Services , Ministry Of Manpower , Singapore Economic Development Board , Futures Commission , Investment Firm , Monetary Authority Of Singapore , Hashkey Capital Singapore , Key Capital , Singapore Fintech Festival , Monetary Authority , Key Capital Singapore , Hashkey Capital , Nov 4 , 022 Prnewswire Hashkey Capital Singapore Pte Ltd Quot , Nd Together With Its Affiliates , He Quot Hashkey Group Announced At Singapore Fintech Festival 2022 That It Has Received Its In Principle Approval For The Capital Markets Services Cms License From Monetary Authority Of Mas Asa Licensed Fund Management Company Lfmc When Granted , He Cms License Will Allow Hashkey Capital Singapore To Conduct Fund Management Services From , Art Of Hashkey Capital , Rides Itself Asa Company Which Takes The Next Step In Bringing Digital Assets Closer To Mainstream Institutional Adoption Quot Singapore Is Quickly Becoming Region 39s Epicentre Of Web3 Innovation Being Recognised By Mas Licensed Fund Management Will Allow Hashkey Capital Contribute And Support Local Community , Hich Is Considereda Significant Accomplishment For Us As One Of The Top Web3 Institutional Investors In Asia , Ashkey Capital Is Prepared To Make Additional Contributions Help The Local Web3 Industrygrow Even More Quot Said Mr Deng Chao , Ashkey Capital Singapore Quot Once The Cms Licenseis Granted , Ashkey Capital Will Be Able To Offer Its Services Institutional And Accredited Investors Moreover ,

Paris EMS Report for Dec. 13 2022

The following report is compiled from an incident list as reported by Paris EMS. ....

Service Unit , Respiratory Arrest , Distance Transfer , Chest Pain , Sick Person , Back Pain , April 1 , April 5 , April 8 , April 15 , April 20 , April 22 , April 25 , April 27 , April 29 , May 9 , May 11 , June 1 , Tjune 3 , June 6 , June 4 , June 11 , Public Service , Mental Case , June 15 , Une 24 ,

Paris EMS Report for Dec. 8, 2022

The following report is compiled from an incident list as reported by Paris EMS. ....

Man Down , Distance Transfer , Chest Pain , Sick Person , Back Pain , April 1 , April 5 , April 8 , April 15 , April 20 , April 22 , April 25 , April 27 , April 29 , May 9 , May 11 , June 1 , Tjune 3 , June 6 , June 4 , June 11 , Public Service , Mental Case , June 15 , Une 24 , July 13 ,

Paris EMS Report for Dec. 6, 2022

The following report is compiled from an incident list as reported by Paris EMS. ....

Fire Department , Respiratory Arrest , Man Down , Distance Transfer , Chest Pain , Sick Person , Back Pain , April 1 , April 5 , April 8 , April 15 , April 20 , April 22 , April 25 , April 27 , April 29 , May 9 , May 11 , June 1 , Tjune 3 , June 6 , June 4 , June 11 , Public Service , Mental Case , June 15 ,